Search

everythinglearnresearchcommunity

for

Search:↓

Combining PRS with TAFR is promising for treating complex fistulas, with most patients achieving long-term healing.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

The TPAP method effectively categorizes androgenetic alopecia patients with high accuracy, but needs real-world validation.

SPET-085 effectively inhibits an enzyme linked to prostate issues, similar to finasteride.

Combining fat grafts with botulinum toxin helps improve Raynaud's symptoms.

Transglutaminase-3 is often reduced in esophageal cancer.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Some drugs for inflammation may cause psoriasis-like hair loss.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Certain variations of the HDAC9 gene can increase or decrease stroke risk in the Chinese population.

Combining excimer lamp and tofacitinib gel may help treat hair loss in children.

TRPV3 channels are involved in skin processes and are affected by shear stress, influencing itch and mechanotransduction.

MPA increases cancer spread by boosting Eph A2 activity.

The document's conclusion cannot be determined without content.

Researchers found a new genetic mutation linked to a hair condition in a Japanese boy.

Tanshinone IIA helps protect tissue from low oxygen damage by activating certain cell pathways.

TTNPB helps turn stem cells into neural stem cells, improving depression-like behaviors in rats.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

TP0427736 may help treat hair loss by blocking a specific protein and promoting hair growth.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

M50054 may help treat hepatitis and hair loss from chemotherapy.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.